Recent News

Share
and/or
Upcoming Seminars and Events

View upcoming seminars and events.

Learn more
519 News Items found
An MSK scientist peers through a microscope
MSK Research Highlights, April 21, 2023

New MSK research finds adherence is a hurdle for home-based colorectal cancer tests; sheds new light on tumor-associated macrophages in glioblastoma; identifies statins as a promising addition to treatment for HER2-positive gastric cancer; and describes how a new single-cell transcriptome atlas opens the “black box” of early human embryo development.
Marie-Josée Kravis Quantitative Biology Fellows Corey Weistuch and Sneha Mitra
Quantitative Biology Fellowship Targets Cancer With Math and Computer Science

Learn about the Marie-Josée Kravis Fellowship in Quantitative Biology, a two-year postdoctoral fellowship that aims to build a new generation of skilled quantitative biologists who specialize in cancer.
Selwyn M. Vickers, MD, FACS, and Andrea Schietinger, PhD
MSK Experts To Receive Prestigious Awards at the American Association for Cancer Research (AACR) 2023 Annual Meeting

Memorial Sloan Kettering Cancer Center (MSK) is pleased to announce that Selwyn M. Vickers, MD, FACS, President and Chief Executive Officer of MSK, and Andrea Schietinger, PhD, Associate Member of the Immunology Program at the Sloan Kettering Institute will be honored at the 2023 American Association for Cancer Research (AACR) Annual Meeting for their significant contributions to cancer research and care.
Luis F. Parada, PhD; Dana Pe’er, PhD; and Michel Sadelain, MD, PhD
Three Memorial Sloan Kettering Cancer Center (MSK) Scientific Leaders Elected as Fellows of the American Association for Cancer Research (AACR) Academy

Memorial Sloan Kettering Cancer Center (MSK) is pleased to announce three faculty are among the 23 international scientific leaders elected today to the prestigious Fellows of the American Association for Cancer Research (AACR) Academy class of 2023. All three are members of the Sloan Kettering Institute, a hub for basic science and translational research within MSK.
Cassidy Cobbs
Transgender Visibility: Meet MSK Cancer Research Staffer Cassidy Cobbs

Cassidy Cobbs is many things: a valued colleague who works at the Sloan Kettering Institute; a doting parent to a pit bull named Mando; a beloved sibling; and a passionate baseball fan, who memorized the stats of former player, Ryne Sandberg, at the age of 5. What Cassidy is not is someone who identifies as either a man or a woman.
Microscopy image showing a quiescent cluster of lung adenocarcinoma tumor cells with low STING expression.
MSK Scientists Identify Potential New Strategy Against Metastasis

A team of scientists at the Sloan Kettering Institute has identified the STING cellular signaling pathway as a key player in keeping dormant cancer cells from progressing into aggressive tumors months, or even years, after they’ve escaped from a primary tumor.
MSK Awards & Appointments January 2023
MSK Awards & Appointments February & March 2023

Memorial Sloan Kettering Cancer Center (MSK) announces the following awards and appointments.
A scientist pipetting in a lab
MSK Research Highlights, March 9, 2023

New research from MSK offers new proof-of-concept compounds against acute myeloid leukemia; reports results from a phase 1 clinical trial appraising two drugs against low- grade glioma; examines MSK’s first-in-the-nation program integrating herbal medicine into oncology care; and identifies how high-grade histologic patterns in lymph node metastases could better predict lung cancer outcomes.
MSK physician-scientists Michele Sadelain, Isabelle Riviere, and Jae Park
Testing CRISPR-Edited CAR T Cell Therapy in Lymphoma Clinical Trial

A groundbreaking clinical trial is testing CAR T cells created using CRISPR gene-editing technology.
SKI biomedical engineer Dr. Daniel Heller
Getting Drugs Across the Blood-Brain Barrier Using Nanoparticles

Learn how MSK researchers are investigating the use of nanoparticles to carry drugs across the blood-brain barrier.